Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by Pandoraon Dec 18, 2021 12:29pm
135 Views
Post# 34243473

RE:RE:RE:RE:RE:RE:RE:RE:How much could be a buyout?

RE:RE:RE:RE:RE:RE:RE:RE:How much could be a buyout?
GrahamB wrote:
LandCruiser1983 wrote: I think your .60cents is a lot closer to the truth than those wierdly high $+ valuations. Come back to reality,this is not a fantasy board.  If we are not seeing any price increases during this peak Covid time,, (it is falling in S.P).  it is not going to happen in the near 1-2 year future.  This is our time to excell but we are floundering. JIHO.


That is my thinking exactly.
60cents is the top end IMO, but they need to show that there is a genuine demand for the product.
Videos and articles that convince investors may move the share price in the short term and is great for tradibg(I see that now), but will not affect the valuation nor even the likelihood of a buyout.
People can handwave all they want -but sales recorded on the Income statement and ideally  cash flow statement will be convincing All IMO



Keep in mind that a few years back when they got the FDA approval the price ran from about 15 cents to 95 cents in about one hours time. (end of February, 2017?). It can be volatile with the right kind of news. Of course we have a boatload more shares mow.
<< Previous
Bullboard Posts
Next >>